Healthcare provider profile · identity verified

Diana Harless

Nurse Practitioner · COLUMBUS, OH · NPI 1083002380

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1055	161
Levothyroxine Sodium	Levothyroxine Sodium	743	104
Amlodipine Besylate	Amlodipine Besylate	740	114
Metoprolol Succinate	Metoprolol Succinate	420	61
Gabapentin	Gabapentin	418	64
Lisinopril	Lisinopril	418	72
Furosemide	Furosemide	410	71
Donepezil Hcl	Donepezil Hcl	397	74
Losartan Potassium	Losartan Potassium	396	55
Sertraline Hcl	Sertraline Hcl	389	68
Omeprazole	Omeprazole	386	59
Pantoprazole Sodium	Pantoprazole Sodium	374	55
Eliquis	Apixaban	369	56
Carvedilol	Carvedilol	321	50
Trazodone Hcl	Trazodone Hcl	311	59
Memantine Hcl	Memantine Hcl	307	53
Potassium Chloride	Potassium Chloride	305	52
Metformin Hcl	Metformin Hcl	281	35
Mirtazapine	Mirtazapine	270	49
Metoprolol Tartrate	Metoprolol Tartrate	264	42
Warfarin Sodium	Warfarin Sodium	255	16
Quetiapine Fumarate	Quetiapine Fumarate	235	39
Buspirone Hcl	Buspirone Hcl	230	41
Clopidogrel	Clopidogrel Bisulfate	225	39
Tamsulosin Hcl	Tamsulosin Hcl	193	35
Famotidine	Famotidine	163	25
Hydrochlorothiazide	Hydrochlorothiazide	158	24
Duloxetine Hcl	Duloxetine Hcl	157	25
Escitalopram Oxalate	Escitalopram Oxalate	157	25
Pravastatin Sodium	Pravastatin Sodium	157	24
Citalopram Hbr	Citalopram Hydrobromide	150	26
Divalproex Sodium	Divalproex Sodium	147	32
Simvastatin	Simvastatin	146	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	124	26
Alendronate Sodium	Alendronate Sodium	123	18
Bupropion Xl	Bupropion Hcl	123	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	113	66
Cephalexin	Cephalexin	112	58
Meloxicam	Meloxicam	109	20
Methenamine Hippurate	Methenamine Hippurate	107	16
Levetiracetam	Levetiracetam	104	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	100	61
Doxycycline Hyclate	Doxycycline Hyclate	96	53
Olanzapine	Olanzapine	91	11
Finasteride	Finasteride	87	16
Rosuvastatin Calcium	Rosuvastatin Calcium	85	15
Tramadol Hcl	Tramadol Hcl	84	28
Jardiance	Empagliflozin	82	14
Pregabalin	Pregabalin	80	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	79	55
Venlafaxine Hcl Er	Venlafaxine Hcl	78	13
Celecoxib	Celecoxib	76	11
Allopurinol	Allopurinol	72	13
Oxybutynin Chloride Er	Oxybutynin Chloride	72	14
Lorazepam	Lorazepam	70	16
Albuterol Sulfate Hfa	Albuterol Sulfate	68	37
Metformin Hcl Er	Metformin Hcl	68	13
Atenolol	Atenolol	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	65	46
Lamotrigine	Lamotrigine	64	suppressed
Tizanidine Hcl	Tizanidine Hcl	63	23
Nifedipine Er	Nifedipine	62	suppressed
Ezetimibe	Ezetimibe	61	suppressed
Alprazolam	Alprazolam	60	suppressed
Montelukast Sodium	Montelukast Sodium	59	12
Aripiprazole	Aripiprazole	53	suppressed
Fluconazole	Fluconazole	51	35
Fluoxetine Hcl	Fluoxetine Hcl	50	suppressed
Hydralazine Hcl	Hydralazine Hcl	50	suppressed
Propranolol Hcl	Propranolol Hcl	50	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	47	suppressed
Xarelto	Rivaroxaban	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	23
Myrbetriq	Mirabegron	46	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	46	11
Torsemide	Torsemide	45	suppressed
Tradjenta	Linagliptin	45	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Nystatin	Nystatin	44	24
Spironolactone	Spironolactone	44	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	42	13
Cefdinir	Cefdinir	41	26
Pioglitazone Hcl	Pioglitazone Hcl	41	suppressed
Latanoprost	Latanoprost	40	13
Loperamide	Loperamide Hcl	40	28
Clonazepam	Clonazepam	38	suppressed
Liothyronine Sodium	Liothyronine Sodium	38	suppressed
Prednisone	Prednisone	38	14
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	16
Azithromycin	Azithromycin	31	20
Doxepin Hcl	Doxepin Hcl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	13
Oxycodone Hcl	Oxycodone Hcl	31	12
Rivastigmine	Rivastigmine Tartrate	31	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	11
Klayesta	Nystatin	30	19
Lansoprazole	Lansoprazole	30	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	30	22
Ramipril	Ramipril	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Bumetanide	Bumetanide	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Mupirocin	Mupirocin	27	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Levofloxacin	Levofloxacin	26	19
Primidone	Primidone	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Vilazodone Hcl	Vilazodone Hcl	26	suppressed
Admelog Solostar	Insulin Lispro	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	12
Klor-Con M20	Potassium Chloride	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	19
Benazepril Hcl	Benazepril Hcl	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Galantamine Hbr	Galantamine Hbr	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Risperidone	Risperidone	23	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	16
Cimetidine	Cimetidine	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Nadolol	Nadolol	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Baclofen	Baclofen	20	suppressed
Calcitriol	Calcitriol	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Leflunomide	Leflunomide	20	suppressed
Amiloride Hcl	Amiloride Hcl	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	18	suppressed
Glipizide	Glipizide	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Alogliptin	Alogliptin Benzoate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Novolog Flexpen	Insulin Aspart	17	13
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Trimethoprim	Trimethoprim	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Gemtesa	Vibegron	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Valproic Acid	Valproic Acid	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Darunavir	Darunavir	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Naproxen	Naproxen	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Isentress	Raltegravir Potassium	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error